Play Live Radio
Next Up:
0:00
0:00
Available On Air Stations
Watch Live

Search results for

  • After 41 days of a government shutdown, the U.S. Senate passed a set of bills to reopen the government. The House comes back to vote as early as Wednesday afternoon.
  • Most of the federal government is shut down after Congress failed to reach a funding agreement. We asked two House members — a Democrat and Republican — where they think talks go from here
  • We sit down with the reporters behind a new investigative series, looking into where new homes are being built in San Diego County and why some development efforts face pushback.
  • The push to rehire retired workers comes as the administration has also sought to downsize large swaths of the federal government through mass layoffs and other changes.
  • At the heart of the impasse is a debate about expiring subsidies for health insurance. It's the latest chapter in a fight over Obamacare that has dominated Congress since the law was signed in 2010.
  • A handful of Republicans joined Democrats to vote against President Trump's emergency tariffs against Brazil, Canada and other countries. But the votes were mostly symbolic and unlikely to become law.
  • Lecture title: Reprogramming the immune system: A new era of precision immunotherapy for cancer and autoimmune disease - Front Row lecture with Travis Young, PhD Description: Your immune system is your body’s natural defense, capable of identifying what belongs and what doesn’t. But when it falters, it can let cancer grow unchecked or mistakenly attack your own healthy tissues, leading to autoimmune diseases. What if we could reprogram the immune system to tip the balance in our favor, gaining an advantage over both cancers and autoimmune disorders? In this free Front Row lecture, Calibr-Skaggs’ vice president of biologics, Travis Young, will share how Scripps Research is using genetic engineering to reprogram patients’ own immune cells to create personalized “switchable” CAR-T cell therapies. This approach represents a new class of precision immunotherapy designed to induce deep and durable remissions in patients with a wide range of cancers, from lymphoma to breast cancer, as well as in chronic autoimmune conditions such as lupus, rheumatoid arthritis and systemic sclerosis. Young will explain how this breakthrough strategy works and what it could mean for the future of medicine. About Scripps Research: Scripps Research is an independent, nonprofit biomedical institute based in La Jolla, California, and ranked one of the most influential in the world for its impact on innovation. The Front Row lecture series, now in its eighth season, offers an exclusive glimpse into groundbreaking scientific discoveries in action. Reserve your seat today and learn how our scientists remain at the forefront of advancing the future of science and medicine. Join us—in the front row. Reserve your seat! Settle into our auditorium for an inspirational, in-person experience, or attend virtually with thousands of people from around the world. Scripps Research on Facebook / Instagram
  • The new film portrays Hitler's second-in-command, Hermann Goering, as a wily mastermind, sidestepping uncomfortable questions about how unexceptional evil can be.
  • On Sept. 2, 1945, the Japanese and the Allies gathered to mark the official end of WWII. The process went smoothly until Col. Lawrence Cosgrave signed his name on the wrong line.
  • The sanctions sharply escalate tensions with the leftist leader of a country that has traditionally been one of the closest U.S. allies in South America.
8 of 883